| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Alan Chait | |
| Theodore Mazzone | |||
| Jorge Plutzky | |||
| P2860 | cites work | Inflammation and insulin resistance | Q22241893 |
| Signal integration in the endoplasmic reticulum unfolded protein response | Q27860577 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| Inflammation and metabolic disorders | Q27860923 | ||
| Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance | Q28131660 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications | Q28253399 | ||
| LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients | Q28270761 | ||
| The hexosamine signaling pathway: deciphering the "O-GlcNAc code" | Q28284365 | ||
| Predominance of a proinflammatory phenotype in monocyte-derived macrophages from subjects with low plasma HDL-cholesterol | Q28290135 | ||
| Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes | Q28299458 | ||
| Monocyte chemotactic protein-1 and its role in insulin resistance | Q28301799 | ||
| A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease | Q28361892 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance | Q29614354 | ||
| HDL cholesterol and atherosclerosis | Q80609115 | ||
| Reinventing type 2 diabetes: pathogenesis, treatment, and prevention | Q80854053 | ||
| High-density lipoproteins enhance progenitor-mediated endothelium repair in mice | Q82781316 | ||
| Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol | Q44766894 | ||
| Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study | Q44895725 | ||
| Susceptibility of low-density lipoprotein to oxidation and circulating cell adhesion molecules in young healthy adult offspring of parents with type 2 diabetes | Q44911467 | ||
| Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes | Q44995615 | ||
| Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase | Q45124403 | ||
| Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study | Q45232445 | ||
| Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial | Q45332825 | ||
| Differential uptake of subfractions of triglyceride-rich lipoproteins by THP-1 macrophages. | Q46504788 | ||
| High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells. | Q46505785 | ||
| Activation of peripheral blood CD14+ monocytes occurs in diabetes | Q46670144 | ||
| High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory | Q46765374 | ||
| Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production | Q46802388 | ||
| Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. | Q52564891 | ||
| Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. | Q54610885 | ||
| Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods | Q58040103 | ||
| Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia | Q59624472 | ||
| The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages | Q60642306 | ||
| Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women | Q61162458 | ||
| Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice | Q64377156 | ||
| Endogenous ApoE expression modulates adipocyte triglyceride content and turnover | Q64377381 | ||
| The effect of insulin and insulin-like growth factors on cell proliferation of human smooth muscle cells. | Q64978805 | ||
| Alterations of elastin and elastase-like activities in aortae of diabetic rats | Q67968589 | ||
| Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque | Q72401496 | ||
| Increased uptake of alpha-hydroxy aldehyde-modified low density lipoprotein by macrophage scavenger receptors | Q73963835 | ||
| AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL | Q79148131 | ||
| Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells | Q79348211 | ||
| T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity | Q79765934 | ||
| Diabetic dyslipidemia | Q80228440 | ||
| High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor | Q80284338 | ||
| Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice | Q80345379 | ||
| TLR4 links innate immunity and fatty acid-induced insulin resistance | Q29617577 | ||
| Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome | Q29619211 | ||
| Effects of torcetrapib in patients at high risk for coronary events | Q29619609 | ||
| A central role for JNK in obesity and insulin resistance | Q29619778 | ||
| CCR2 modulates inflammatory and metabolic effects of high-fat feeding | Q29622869 | ||
| Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial | Q29622926 | ||
| MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial | Q33966645 | ||
| Clinical review 124: Diabetic dyslipidemia: causes and consequences | Q34174659 | ||
| Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes | Q34180296 | ||
| Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway | Q34229420 | ||
| Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus | Q34371741 | ||
| Circuitry of nuclear factor kappaB signaling | Q34514908 | ||
| Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial | Q34572519 | ||
| Mechanisms linking obesity with cardiovascular disease | Q34590832 | ||
| Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials | Q34601330 | ||
| Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase | Q34808268 | ||
| Scavenger receptors that recognize advanced glycation end products | Q34871996 | ||
| The function of leptin in nutrition, weight, and physiology | Q34981685 | ||
| Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to cholesterol metabolism | Q35079451 | ||
| Transcriptional control of apolipoprotein A-I gene expression in diabetes | Q35677407 | ||
| Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. | Q35691127 | ||
| Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines | Q35749970 | ||
| Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones | Q35794061 | ||
| Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation? | Q35802181 | ||
| Antiinflammatory properties of HDL. | Q35919164 | ||
| Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance | Q36002036 | ||
| Nuclear factor kappaB signaling in atherogenesis. | Q36054434 | ||
| Adipose tissue, inflammation, and cardiovascular disease | Q36125401 | ||
| Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis | Q36294176 | ||
| Role of nitric oxide in diabetic complications. | Q36310430 | ||
| From mice to men: insights into the insulin resistance syndromes | Q36387884 | ||
| Retinaldehyde represses adipogenesis and diet-induced obesity. | Q36444754 | ||
| Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state | Q36459935 | ||
| Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? | Q36492920 | ||
| Diabetic atherosclerosis mouse models | Q36595540 | ||
| Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes | Q36688361 | ||
| Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets | Q36721566 | ||
| Adipose tissue and atherosclerosis: exploring the connection | Q36736914 | ||
| Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. | Q36755963 | ||
| ESCI Award 2006. Mitochondrial function and endocrine diseases | Q36764954 | ||
| Mechanisms for oxidative stress in diabetic cardiovascular disease | Q36824967 | ||
| The macrophage at the crossroads of insulin resistance and atherosclerosis | Q36843648 | ||
| Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. | Q36883079 | ||
| Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease | Q36910684 | ||
| Fatty acid-induced atherogenic changes in extracellular matrix proteoglycans | Q36947999 | ||
| High glucose induces IL-1beta expression in human monocytes: mechanistic insights | Q37176774 | ||
| Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes | Q37371121 | ||
| Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation | Q37372004 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis | Q37643127 | ||
| 5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation | Q38303459 | ||
| Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. | Q38309468 | ||
| Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus | Q40102509 | ||
| Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. | Q40117639 | ||
| Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway | Q40166045 | ||
| Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women | Q40192779 | ||
| Fatty acid composition of chylomicron remnant-like particles influences their uptake and induction of lipid accumulation in macrophages. | Q40209874 | ||
| Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study | Q40245380 | ||
| LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). | Q40317506 | ||
| Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux | Q40390167 | ||
| Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha | Q40701120 | ||
| Inflamed fat: what starts the fire? | Q40899161 | ||
| Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL. | Q40930144 | ||
| Dietary polyunsaturated fat modifies low-density lipoproteins and reduces atherosclerosis of nonhuman primates with high and low diet responsiveness | Q41677709 | ||
| Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation | Q42483749 | ||
| Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta. | Q42486345 | ||
| The unfolded protein response is an important regulator of inflammatory genes in endothelial cells | Q42500350 | ||
| In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. | Q42536696 | ||
| The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species | Q42823731 | ||
| Divergent effects of peroxisome proliferator-activated receptor gamma agonists and tumor necrosis factor alpha on adipocyte ApoE expression. | Q42826013 | ||
| Post-prandial remnant lipids impair arterial compliance | Q43636292 | ||
| Diabetes-induced accelerated atherosclerosis in swine | Q43651836 | ||
| Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation | Q43763511 | ||
| Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content | Q43797645 | ||
| Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study | Q44063976 | ||
| Progesterone inhibits human infragenicular arterial smooth muscle cell proliferation induced by high glucose and insulin concentrations | Q44170918 | ||
| Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance | Q44286392 | ||
| Statins inhibit high glucose-mediated neutrophil-endothelial cell adhesion through decreasing surface expression of endothelial adhesion molecules by stimulating production of endothelial nitric oxide | Q44397510 | ||
| Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha | Q44583814 | ||
| Mechanisms involved in the stimulatory effect of advanced glycation end products on growth of rat aortic smooth muscle cells | Q44688770 | ||
| P433 | issue | 9626 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 1800-1809 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies | |
| P478 | volume | 371 |
| Q83461067 | "Does imaging paint a sugar-coated picture of diabetic vessels?" : plaque composition in diabetics by IVUS and CT angiography |
| Q35040571 | A Drug-Target Network-Based Approach to Evaluate the Efficacy of Medicinal Plants for Type II Diabetes Mellitus |
| Q41488066 | A hepatic amino acid/mTOR/S6K-dependent signalling pathway modulates systemic lipid metabolism via neuronal signals |
| Q37560339 | A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus |
| Q43015737 | A possible mechanism linking hyperglycemia and reduced high-density lipoprotein cholesterol levels in diabetes. |
| Q33561396 | A review of cardiovascular risks associated with medications used to treat type-2 diabetes mellitus |
| Q37969832 | A review of the evidence for the effects of total dietary fat, saturated, monounsaturated and n-6 polyunsaturated fatty acids on vascular function, endothelial progenitor cells and microparticles |
| Q37694033 | A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress |
| Q64099265 | ATP-binding cassette sub-family a member1 gene mutation improves lipid metabolic abnormalities in diabetes mellitus |
| Q92220093 | Activation of TGR5 Partially Alleviates High Glucose-Induced Cardiomyocyte Injury by Inhibition of Inflammatory Responses and Oxidative Stress |
| Q87804928 | Acute Hypoglycemic and Antidiabetic Effect of Teuhetenone A Isolated from Turnera diffusa |
| Q40287232 | Adaptive Upregulation of Clumping Factor A (ClfA) by Staphylococcus aureus in the Obese, Type 2 Diabetic Host Mediates Increased Virulence |
| Q35688028 | Administration of pioglitazone alone or with alogliptin delays diabetes onset in UCD-T2DM rats. |
| Q41969432 | Akt2 deficiency promotes cardiac induction of Rab4a and myocardial β-adrenergic hypersensitivity. |
| Q89921001 | Antioxidant Blueberry Anthocyanins Induce Vasodilation via PI3K/Akt Signaling Pathway in High-Glucose-Induced Human Umbilical Vein Endothelial Cells |
| Q57789721 | Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease |
| Q51319962 | Association between HOMA-IR, fasting insulin and fasting glucose with coronary heart disease mortality in nondiabetic men: a 20-year observational study. |
| Q28481738 | Association between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: cross-sectional study |
| Q34928909 | Association between urinary 8-OHdG and pulse wave velocity in hypertensive patients with type 2 diabetes mellitus |
| Q36629664 | Association between urinary markers of nucleic acid oxidation and mortality in type 2 diabetes: a population-based cohort study. |
| Q41380824 | Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans |
| Q35809770 | Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies |
| Q46557142 | Biomechanical factors in diabetic foot disease |
| Q39197051 | Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus |
| Q34380424 | C-reactive protein + 1059 G>C polymorphism in type 2 diabetes and coronary artery disease patients |
| Q37022090 | CD226 reduces endothelial cell glucose uptake under hyperglycemic conditions with inflammation in type 2 diabetes mellitus |
| Q38042321 | CD40-CD40L: linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications |
| Q45977862 | Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. |
| Q39451162 | Can nitric oxide-releasing hybrid drugs alleviate adverse cardiovascular risks? |
| Q89580211 | Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review |
| Q34552494 | Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy |
| Q37611715 | Cardiovascular Benefits of Native GLP-1 and its Metabolites: An Indicator for GLP-1-Therapy Strategies |
| Q36484283 | Cardiovascular biology of the incretin system |
| Q33602366 | Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008 |
| Q38113092 | Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes |
| Q36758314 | Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up |
| Q36426708 | Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. |
| Q28565448 | Changes in expression and activity of the secretory pathway Ca2+ ATPase 1 (SPCA1) in A7r5 vascular smooth muscle cells cultured at different glucose concentrations |
| Q35168391 | Characterization of sleep breathing pattern in patients with type 2 diabetes: sweet sleep study. |
| Q60961963 | Chemical Characterization and Hypoglycaemic Activities In Vitro of Two Polysaccharides from by Submerged Culture |
| Q38633260 | Chemoprotective effects of butanol fraction of Buchholzia Coriacea ( Capparidaceae ) against Type 2 Diabetes and Oxidative Stress in male Wistar rats |
| Q36356877 | Chikusetsu saponin IVa confers cardioprotection via SIRT1/ERK1/2 and Homer1a pathway. |
| Q35756854 | Comparative Efficacy and Safety of Laparoscopic Greater Curvature Plication and Laparoscopic Sleeve Gastrectomy: A Meta-analysis |
| Q36303829 | Comparison of Laparoscopic Sleeve Gastrectomy and Laparoscopic Greater Curvature Plication Regarding Efficacy and Safety: a Meta-Analysis |
| Q36018338 | Comparison of the effect of bone marrow cells infusion through the portal vein and inferior vena cava combined with short-term rapamycin on allogeneic islet grafts in diabetic rats |
| Q35898244 | Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study |
| Q57256740 | Coronary triglyceride deposition in contemporary advanced diabetics |
| Q90364685 | Could remnant-like particle cholesterol become a risk factor in diabetic menopausal women with coronary artery disease? A cross-sectional study of single academic center in China |
| Q58229736 | Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology |
| Q37333371 | Diabetes and atherosclerosis: is there a role for hyperglycemia? |
| Q34716791 | Diabetes and cardiovascular disease: the potential benefit of incretin-based therapies |
| Q41383829 | Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice |
| Q34139156 | Diabetes mellitus and its impact on long-term outcomes after coronary artery bypass graft surgery |
| Q42964142 | Diabetes-accelerated atherosclerosis and inflammation |
| Q37319716 | Diabetic dyslipidemia and cardiovascular risk |
| Q34044884 | Diabetic impairment of C-kit bone marrow stem cells involves the disorders of inflammatory factors, cell adhesion and extracellular matrix molecules |
| Q34947370 | Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance |
| Q38034678 | Direct effects of adipokines on the heart: focus on adiponectin |
| Q42872773 | Disruption of Rac1 signaling reduces ischemia–reperfusion injury in the diabetic heart by inhibiting calpain |
| Q90481556 | Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus |
| Q39826326 | Dual PPAR α / γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia |
| Q46200304 | Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile |
| Q56089326 | Effect of multispecies probiotic supplements on serum minerals, liver enzymes and blood pressure in patients with type 2 diabetes |
| Q37370870 | Effect of trimetazidine treatment on the transient outward potassium current of the left ventricular myocytes of rats with streptozotocin-induced type 1 diabetes mellitus |
| Q37177142 | Effects of pure eicosapentaenoic and docosahexaenoic acids on oxidative stress, inflammation and body fat mass in patients with type 2 diabetes. |
| Q35189566 | Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study |
| Q47994395 | Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) - receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes |
| Q36387626 | Elevated Levels of Urinary Markers of Oxidative DNA and RNA Damage in Type 2 Diabetes with Complications |
| Q34362848 | Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences |
| Q38011272 | Evidence for using alpha-lipoic acid in reducing lipoprotein and inflammatory related atherosclerotic risk |
| Q38058381 | Examining the safety of PPAR agonists - current trends and future prospects |
| Q28472170 | Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications |
| Q47138160 | Extracellular Vesicles as Protagonists of Diabetic Cardiovascular Pathology. |
| Q37228675 | Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial |
| Q34501763 | Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors |
| Q50153346 | Gallstone disease associated with increased risk of arterial stiffness in a Taiwanese population |
| Q38200673 | Gamma-glutamyltransferase predicts increased risk of mortality: a systematic review and meta-analysis of prospective observational studies |
| Q34420387 | Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes |
| Q38905127 | Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes. |
| Q39635352 | Glabridin, a phytoestrogen from licorice root, up‐regulates manganese superoxide dismutase, catalase and paraoxonase 2 under glucose stress |
| Q36195926 | Glucose control and cardiovascular outcomes: reorienting approach |
| Q37982850 | Glucose control in diabetes: which target level to aim for? |
| Q60922054 | HSP22 suppresses diabetes-induced endothelial injury by inhibiting mitochondrial reactive oxygen species formation |
| Q34264599 | HbA1c and coronary heart disease risk among diabetic patients. |
| Q43007648 | High glucose induces apoptosis in AC16 human cardiomyocytes via macrophage migration inhibitory factor and c-Jun N-terminal kinase |
| Q46956607 | High glucose-induced jagged 1 in endothelial cells disturbs notch signaling for angiogenesis: a novel mechanism of diabetic vasculopathy |
| Q35177141 | How do high glycemic load diets influence coronary heart disease? |
| Q50914584 | Hydrogen sulfide inhibits high-glucose-induced apoptosis in neonatal rat cardiomyocytes. |
| Q44477805 | Hyperglycaemia and coronary heart disease: the meta picture |
| Q55176268 | Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care. |
| Q34505220 | I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice |
| Q41977926 | Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respiration |
| Q37152130 | Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population. |
| Q39872606 | Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief Report |
| Q36980202 | Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study |
| Q36249831 | Impaired MEK signaling and SERCA expression promote ER stress and apoptosis in insulin-resistant macrophages and are reversed by exenatide treatment |
| Q36689801 | Impaired cardioprotective function of transplantation of mesenchymal stem cells from patients with diabetes mellitus to rats with experimentally induced myocardial infarction |
| Q36560261 | Impaired fasting glucose and risk of cardiovascular disease in Korean men and women: the Korean Heart Study |
| Q37110310 | Impaired retinal vasodilator responses in prediabetes and type 2 diabetes |
| Q52655804 | Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr-/-ApoB100/100 mouse model. |
| Q41882168 | Incretin hormones as immunomodulators of atherosclerosis. |
| Q50782080 | Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy. |
| Q46975544 | Influence of high blood glucose fluctuation on endothelial function of type 2 diabetes mellitus rats and effects of Panax Quinquefolius Saponin of stem and leaf |
| Q38198953 | Insulin resistance and hyperglycaemia in cardiovascular disease development |
| Q37784325 | Intensive Glucose Control and Cardiovascular Outcomes in Type 2 Diabetes |
| Q33753663 | Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data |
| Q37734216 | Intensive glycemic control and cardiovascular disease: an update |
| Q33773168 | Investigation of ABCA1 C69T polymorphism in patients with type 2 diabetes mellitus |
| Q37577137 | Is glucose control important for prevention of cardiovascular disease in diabetes? |
| Q44392355 | Ischemic stroke in prediabetic patients. |
| Q45918200 | Kalpaamruthaa modulates oxidative stress in cardiovascular complication associated with type 2 diabetes mellitus through PKC-β/Akt signaling. |
| Q37242976 | LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro |
| Q37945097 | LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications |
| Q35750322 | LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2. |
| Q33602487 | Leptin revisited: its mechanism of action and potential for treating diabetes |
| Q38065316 | Leptin therapy in type 2 diabetes |
| Q35886333 | Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients |
| Q37853015 | Lipid control in patients with diabetes mellitus |
| Q84393166 | Lipid disorders in type 2 diabetes |
| Q35140825 | Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes |
| Q35763055 | Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation. |
| Q35082511 | Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways |
| Q30426876 | Localized micro- and nano-scale remodelling in the diabetic aorta |
| Q33894535 | Long sleep duration associated with a higher risk of increased arterial stiffness in males. |
| Q46742553 | Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells |
| Q58696244 | Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice |
| Q27687298 | Lymphocyte roles in metabolic dysfunction: of men and mice |
| Q64262692 | Management of diabetic dyslipidemia: An update |
| Q33935729 | Management of hypertriglyceridemia in the diabetic patient |
| Q37102861 | Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes |
| Q33553625 | Mechanism for endogenously expressed ApoE modulation of adipocyte very low density lipoprotein metabolism: role in endocytic and lipase-mediated metabolic pathways |
| Q38589032 | Mechanisms for the cardiovascular effects of glucagon-like peptide-1. |
| Q50768047 | Mild chronic kidney disease associated with greater risk of arterial stiffness in elderly adults. |
| Q33631921 | Minireview: Challenges and opportunities in development of PPAR agonists |
| Q37411158 | Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes |
| Q34979907 | Novel KIF6 polymorphism increases susceptibility to type 2 diabetes mellitus and coronary heart disease in Han Chinese men |
| Q46458284 | Nrf2 Activation as a Protective Feedback to Limit Cell Death in High Glucose-Exposed Cardiomyocytes |
| Q30463385 | Obstructive sleep apnea and type 2 diabetes: is there a link? |
| Q30473890 | Obstructive sleep apnea: Role in the risk and severity of diabetes |
| Q35830460 | Occurrence of increased arterial stiffness in a cohort of adult patients with type 1 diabetes mellitus when compared to normoglycemic controls |
| Q34455196 | Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction. |
| Q28569684 | Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction |
| Q27692635 | Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications |
| Q47134510 | Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus |
| Q51891592 | Overexpression of Jazf1 induces cardiac malformation through the upregulation of pro-apoptotic genes in mice. |
| Q37397476 | PKCβ promotes vascular inflammation and acceleration of atherosclerosis in diabetic ApoE null mice |
| Q37996437 | PPAR agonists for the treatment of cardiovascular disease in patients with diabetes |
| Q53332695 | PPARα agonist prevented the apoptosis induced by glucose and fatty acid in neonatal cardiomyocytes. |
| Q38101961 | Percutaneous coronary intervention in diabetic patients: should choice of stents be influenced? |
| Q37357337 | Pharmacologic therapy for coronary atherosclerosis in patients with Type 2 diabetes mellitus |
| Q34620604 | Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin |
| Q37699834 | Plasma Antimicrobial Peptide LL-37 Level Is Inversely Associated with HDL Cholesterol Level in Patients with Type 2 Diabetes Mellitus. |
| Q42167264 | Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4. |
| Q36051940 | Progression of Diabetic Capillary Occlusion: A Model |
| Q33553042 | Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells |
| Q36443768 | Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians |
| Q42216495 | Regulation of AT1R expression through HuR by insulin |
| Q42284569 | Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study |
| Q54939024 | Relation of Insulin Resistance to Longitudinal Changes in Left Ventricular Structure and Function in a General Population. |
| Q37163809 | Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes |
| Q90539112 | Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease |
| Q38042591 | Renalase, hypertension, and kidney - the discussion continues |
| Q35765497 | Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy |
| Q37536067 | Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications |
| Q38000380 | Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited |
| Q33667869 | Roles of fasting and postprandial blood glucose in the effect of type 2 diabetes on central arterial stiffness: a 5-year prospective community-based analysis |
| Q30357364 | STAT4 contributes to adipose tissue inflammation and atherosclerosis. |
| Q38352759 | Saroglitazar for the treatment of dyslipidemia in diabetic patients |
| Q38790569 | Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders |
| Q46517140 | Serum vascular adhesion protein-1 level is higher in smokers than non-smokers. |
| Q28304388 | Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes |
| Q41993432 | Shared genetic regulatory networks for cardiovascular disease and type 2 diabetes in multiple populations of diverse ethnicities in the United States |
| Q35843423 | Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice |
| Q91130409 | Simple renal cysts are associated with increased arterial stiffness in a Taiwanese population |
| Q33851293 | Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis |
| Q47097583 | Sitagliptin attenuates high glucose-induced alterations in migration, proliferation, calcification and apoptosis of vascular smooth muscle cells through ERK1/2 signal pathway |
| Q90731706 | Skeletal muscle mass to visceral fat area ratio is an important determinant associated with type 2 diabetes and metabolic syndrome |
| Q36000012 | Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice |
| Q28481709 | Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial |
| Q43584656 | Supplementation of cyanidin-3-O-β-glucoside promotes endothelial repair and prevents enhanced atherogenesis in diabetic apolipoprotein E-deficient mice |
| Q47654319 | Synergistic effect of HIF-1α and FoxO3a trigger cardiomyocyte apoptosis under hyperglycemic ischemia condition |
| Q37504375 | Tailored support for type 2 diabetes patients with an acute coronary event after discharge from hospital - design and development of a randomised controlled trial |
| Q40253244 | Tauroursodeoxycholic acid attenuates lipid accumulation in endoplasmic reticulum-stressed macrophages |
| Q37041677 | The 30-year cardiovascular risk profile of South Africans with diagnosed diabetes, undiagnosed diabetes, pre-diabetes or normoglycaemia: the Bellville, South Africa pilot study |
| Q37335147 | The Effects of Diabetes Mellitus in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting. |
| Q42376634 | The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation |
| Q90859261 | The association between metabolic syndrome components and the development of atherosclerosis |
| Q38246002 | The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management |
| Q46810282 | The hexosamine biosynthetic pathway can mediate myocardial apoptosis in a rat model of diet-induced insulin resistance. |
| Q38719186 | The impact of abnormal glucose regulation on arterial stiffness at 3 and 15 months after kidney transplantation. |
| Q35376124 | The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence |
| Q35315854 | The mechanism by which moderate alcohol consumption influences coronary heart disease |
| Q35731801 | The mechanisms by which antidepressants may reduce coronary heart disease risk |
| Q38099275 | The role of endothelial insulin signaling in the regulation of glucose metabolism |
| Q49689988 | Treatment of Dyslipidemia in Diabetes: Recent Advances and Remaining Questions |
| Q46133991 | Type 2 diabetes and coronary heart disease: focus on myocardial infarction |
| Q28073342 | Update on the treatment of type 2 diabetes mellitus |
| Q37707267 | Urinary biomarkers involved in type 2 diabetes: a review. |
| Q35563607 | Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients |
| Q37380419 | Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling |
| Q42686515 | Vascular adhesion protein-1 and renalase in regard to diabetes in hemodialysis patients. |
| Q33599915 | Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant |
| Q37718071 | Vasoconstrictor prostanoids |
| Q30318169 | [Protein glycation as a pathological mechanism in diabetes]. |
| Q35023161 | n-3 Fatty Acids Decrease Arterial Low-Density Lipoprotein Cholesterol Delivery and Lipoprotein Lipase Levels in Insulin-Resistant Mice |
Search more.